Big Data Analysis of OSA Patients on Positive Airway Pressure (PAP) Treatment: Real-life Monitoring (TeleVAL)
Big Data Analysis of OSA Patients on Positive Airway Pressure (PAP) Treatment: Real-life Monitoring: TeleVAL Study
The present study aims to determine to what extent remote monitoring of PAP related to patients' clinical parameters is able to provide relevant data on predictors of compliance, subgroups of patients who may benefit from this technological tool, variations in AHI over time, occurrence of central events at the start of therapy and, in short, to shed new light on this disease and its treatment, all within the application of continuous positive pressure therapy in the real world.
Among the intended objectives is the identification of phenotypes involved in the use and efficacy of PAP therapy: development of a predictive model, as well as the evaluation of the impact of long-term telemonitoring of patients with Obstructive Sleep Apnea (OSA).
The study initially arose from the need to diagnose, treat and follow up patients with suspected OSA in compliance with the social distancing rules imposed by the COVID-19 pandemic.
It is an ambispective cohort study, with retrospective data collection from the start date of the pandemic (March 2020) to December 2021, and prospective data collection from the approval of the protocol to December 2022.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Forventet)
Kontakter og plasseringer
Studiekontakt
- Navn: monica Gonzalez
- Telefonnummer: +34942203389
- E-post: monica.gonzalezm@scsalud.es
Studer Kontakt Backup
- Navn: Lucía Lavin
- Telefonnummer: +34942203389
- E-post: eclinicos5@idival.org
Studiesteder
-
-
Cantabria
-
Santander, Cantabria, Spania, 39008
- Rekruttering
- Hospital Universitario Marqués de Valdecilla
-
Ta kontakt med:
- Monica Gonzalez
- E-post: monica.gonzalezm@scsalud.es
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- All patients diagnosed with OSA since March 2020 with indication for treatment with PAP have been telemonitored on an ongoing basis since initiation of therapy continuing to be telemonitored at the current time.
Exclusion Criteria:
- Undiagnosed OSA patients
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Registry of patients
|
All patients diagnosed with OSA since March 2020 with an indication for treatment with PAP have been telemonitored permanently since the start of therapy and continue to be telemonitored at the present time.
Data are sent remotely daily to the telemonitoring platform.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Characterize the phenotypes involved
Tidsramme: pandemic start date March 2020 until December 2022.
|
Determine the emergent CSA appearance in relation to PAP treatment.
|
pandemic start date March 2020 until December 2022.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Establish the percentage of patients who at the first connection to the TM achieved the optimal therapeutic pressure
Tidsramme: pandemic start date March 2020 until December 2022.
|
According to Built in software (BIS) of the equipment
|
pandemic start date March 2020 until December 2022.
|
|
Establish the Profile of patients who at the first connection to the TM achieved the optimal therapeutic pressure
Tidsramme: pandemic start date March 2020 until December 2022.
|
According to Built in software (BIS) of the equipment
|
pandemic start date March 2020 until December 2022.
|
|
Variations in AHI during the first year of follow-up and their relationship with patient characteristics.
Tidsramme: pandemic start date March 2020 until December 2022.
|
pandemic start date March 2020 until December 2022.
|
|
|
Time to achieve the optimal therapeutic pressure described after the first connection
Tidsramme: pandemic start date March 2020 until December 2022.
|
Number of modifications required and their relationship with patient subgroups.
|
pandemic start date March 2020 until December 2022.
|
|
Evaluation of the impact of long-term telemonitoring of patients with OSA
Tidsramme: pandemic start date March 2020 until December 2022.
|
Number of acesses and interventions made to the telemonitoring platform/year and time invested
|
pandemic start date March 2020 until December 2022.
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- TeleVAL
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .